• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines.微小RNA-222通过靶向基质金属蛋白酶1(MMP1)和锰超氧化物歧化酶2(SOD2)调控舌鳞状细胞癌细胞系的细胞侵袭。
Cancer Genomics Proteomics. 2009 May-Jun;6(3):131-9.
2
MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinoma.微小RNA-21通过靶向舌鳞状细胞癌中的15-羟基前列腺素脱氢酶来调节前列腺素E2信号通路。
BMC Cancer. 2016 Aug 25;16(1):685. doi: 10.1186/s12885-016-2716-0.
3
Deregulation of manganese superoxide dismutase (SOD2) expression and lymph node metastasis in tongue squamous cell carcinoma.锰超氧化物歧化酶(SOD2)表达失调与舌鳞癌淋巴结转移的关系。
BMC Cancer. 2010 Jul 9;10:365. doi: 10.1186/1471-2407-10-365.
4
Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.长链非编码 RNA HOTTIP 下调通过 HMGA2 介导的 Wnt/β-连环蛋白通路抑制口腔舌鳞癌细胞的增殖、迁移和侵袭。
Cancer Biother Radiopharm. 2020 Nov;35(9):720-730. doi: 10.1089/cbr.2019.3017. Epub 2020 Jan 8.
5
Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.舌鳞状细胞癌中miR-222-ABCG2调控模块的失调导致化疗耐药并增强迁移/侵袭潜能。
Oncotarget. 2015 Dec 29;6(42):44538-50. doi: 10.18632/oncotarget.6253.
6
MicroRNA and protein profiles in invasive versus non-invasive oral tongue squamous cell carcinoma cells in vitro.体外侵袭性与非侵袭性口腔舌鳞状细胞癌细胞中的微小RNA和蛋白质谱
Exp Cell Res. 2017 Jan 1;350(1):9-18. doi: 10.1016/j.yexcr.2016.10.015. Epub 2016 Oct 20.
7
SOD2 is a C-myc target gene that promotes the migration and invasion of tongue squamous cell carcinoma involving cancer stem-like cells.超氧化物歧化酶2(SOD2)是一种C-myc靶基因,它促进涉及癌症干细胞样细胞的舌鳞状细胞癌的迁移和侵袭。
Int J Biochem Cell Biol. 2015 Mar;60:139-46. doi: 10.1016/j.biocel.2014.12.022. Epub 2015 Jan 9.
8
The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.基质金属蛋白酶-8、转化生长因子-β1和血管内皮生长因子-C之间的相互作用共同促进了口腔舌鳞状细胞癌的侵袭性。
Br J Cancer. 2017 Sep 26;117(7):1007-1016. doi: 10.1038/bjc.2017.249. Epub 2017 Aug 3.
9
Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling.锰超氧化物歧化酶通过 H2O2 依赖的 Snail 信号诱导舌鳞癌细胞的迁移和侵袭。
Free Radic Biol Med. 2012 Jul 1;53(1):44-50. doi: 10.1016/j.freeradbiomed.2012.04.031. Epub 2012 May 9.
10
miR-34a inhibits migration and invasion of tongue squamous cell carcinoma via targeting MMP9 and MMP14.微小RNA-34a通过靶向基质金属蛋白酶9和基质金属蛋白酶14抑制舌鳞状细胞癌的迁移和侵袭。
PLoS One. 2014 Sep 30;9(9):e108435. doi: 10.1371/journal.pone.0108435. eCollection 2014.

引用本文的文献

1
Manganese Superoxide Dismutase: Structure, Function, and Implications in Human Disease.锰超氧化物歧化酶:结构、功能及其在人类疾病中的意义
Antioxidants (Basel). 2025 Jul 10;14(7):848. doi: 10.3390/antiox14070848.
2
Knockdown of LRP5 Promotes Proliferation and Invasion of Tongue Squamous Cell Carcinoma through Compensatory Activation of Akt Signaling.敲低LRP5通过Akt信号通路的代偿性激活促进舌鳞状细胞癌的增殖和侵袭。
J Cancer. 2024 Apr 15;15(10):3215-3226. doi: 10.7150/jca.93585. eCollection 2024.
3
miR-29c-3p Attenuates beta-Amyloid-Induced Neurotoxicity in Alzheimer's Disease Through Regulating beta-Site Amyloid Precursor Protein-Cleaving Enzyme 1.miR-29c-3p 通过调控β-淀粉样前体蛋白裂解酶 1 减轻阿尔茨海默病中的β-淀粉样蛋白诱导的神经毒性。
Physiol Res. 2023 Dec 31;72(6):833-841. doi: 10.33549/physiolres.935084.
4
miRNA in head and neck squamous cell carcinomas: promising but still distant future of personalized oncology.头颈部鳞状细胞癌中的微小RNA:个性化肿瘤学前景光明但仍任重道远
Rep Pract Oncol Radiother. 2023 Nov 16;28(5):681-697. doi: 10.5603/rpor.96666. eCollection 2023.
5
MicroRNA expression profiles associated with the metastatic ability of MDA‑MB‑231 breast cancer cells.与MDA-MB-231乳腺癌细胞转移能力相关的微小RNA表达谱
Oncol Lett. 2023 Jun 22;26(2):339. doi: 10.3892/ol.2023.13926. eCollection 2023 Aug.
6
miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells.微小RNA-623靶向基质金属蛋白酶-1并减弱脑转移三阴性乳腺癌细胞的外渗。
Breast Cancer (Dove Med Press). 2022 Aug 1;14:187-198. doi: 10.2147/BCTT.S372083. eCollection 2022.
7
, a Potential Transcriptional Target Underpinning CD44-Promoted Breast Cancer Progression.miR-125b-5p, 一个潜在的转录靶点,为 CD44 促进乳腺癌进展提供了基础。
Molecules. 2022 Jan 26;27(3):811. doi: 10.3390/molecules27030811.
8
LINC01783 accelerated tongue squamous cell carcinoma progression via inhibiting miR-199b-5p.LINC01783 通过抑制 miR-199b-5p 促进舌鳞癌细胞的进展。
J Cell Mol Med. 2021 Sep;25(17):8140-8147. doi: 10.1111/jcmm.16352. Epub 2021 Aug 7.
9
The SWI/SNF complex regulates the expression of miR-222, a tumor suppressor microRNA in lung adenocarcinoma.SWI/SNF 复合物调节 miR-222 的表达,miR-222 是肺腺癌中的一种肿瘤抑制 microRNA。
Hum Mol Genet. 2021 Nov 16;30(23):2263-2271. doi: 10.1093/hmg/ddab187.
10
Micro RNAs in Regulation of Cellular Redox Homeostasis.微小 RNA 在细胞氧化还原稳态调节中的作用。
Int J Mol Sci. 2021 Jun 2;22(11):6022. doi: 10.3390/ijms22116022.

本文引用的文献

1
MicroRNA profiling and head and neck cancer.微小RNA分析与头颈癌
Comp Funct Genomics. 2009;2009:837514. doi: 10.1155/2009/837514. Epub 2009 Jun 1.
2
Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222.凝血酶通过下调p27Kip1,同时上调Skp2和MiR-222,诱导肿瘤细胞周期激活和自发生长。
Cancer Res. 2009 Apr 15;69(8):3374-81. doi: 10.1158/0008-5472.CAN-08-4290. Epub 2009 Apr 7.
3
MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1.微小RNA-221/222通过靶向p27Kip1赋予乳腺癌对他莫昔芬的耐药性。
J Biol Chem. 2008 Oct 31;283(44):29897-903. doi: 10.1074/jbc.M804612200. Epub 2008 Aug 15.
4
miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.微小RNA-206在雌激素受体α阳性的人类乳腺癌中表达下调。
Cancer Res. 2008 Jul 1;68(13):5004-8. doi: 10.1158/0008-5472.CAN-08-0180.
5
Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.miRNA-146 的表达抑制 NF-κB 活性,降低乳腺癌细胞的转移潜能。
Oncogene. 2008 Sep 18;27(42):5643-7. doi: 10.1038/onc.2008.171. Epub 2008 May 26.
6
Proteomic based identification of manganese superoxide dismutase 2 (SOD2) as a metastasis marker for oral squamous cell carcinoma.基于蛋白质组学鉴定锰超氧化物歧化酶2(SOD2)作为口腔鳞状细胞癌的转移标志物。
Cancer Genomics Proteomics. 2008 Mar-Apr;5(2):85-94.
7
Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue.成熟的miR-184作为舌鳞状细胞癌潜在的致癌微小RNA
Clin Cancer Res. 2008 May 1;14(9):2588-92. doi: 10.1158/1078-0432.CCR-07-0666.
8
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.口腔癌中因DNA高甲基化而沉默的肿瘤抑制性微小RNA的探索
Cancer Res. 2008 Apr 1;68(7):2094-105. doi: 10.1158/0008-5472.CAN-07-5194.
9
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target.肝细胞癌中微小RNA表达谱分析显示微小RNA-224上调且凋亡抑制因子-5为微小RNA-224特异性靶点。
J Biol Chem. 2008 May 9;283(19):13205-15. doi: 10.1074/jbc.M707629200. Epub 2008 Mar 4.
10
Transcriptomic dissection of tongue squamous cell carcinoma.舌鳞状细胞癌的转录组剖析
BMC Genomics. 2008 Feb 6;9:69. doi: 10.1186/1471-2164-9-69.

微小RNA-222通过靶向基质金属蛋白酶1(MMP1)和锰超氧化物歧化酶2(SOD2)调控舌鳞状细胞癌细胞系的细胞侵袭。

MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines.

作者信息

Liu Xiqiang, Yu Jinsheng, Jiang Lu, Wang Anxun, Shi Fei, Ye Hui, Zhou Xiaofeng

机构信息

Center for Molecular Biology of Oral Diseases, College of Dentistry, University of Illinois at Chicago, Chicago, IL 60612-7213, USA.

出版信息

Cancer Genomics Proteomics. 2009 May-Jun;6(3):131-9.

PMID:19487542
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2890246/
Abstract

MicroRNA deregulation is involved in tumor initiation and progression. The aim of this study was to identify and validate the microRNA candidates that contribute to the metastasis of oral tongue squamous cell carcinoma (OTSCC). Using microarrays, a panel of differentially expressed microRNAs was identified in paired OTSCC cell lines with different metastatic potential. Selected microRNA candidates (including hsa-miR-222) were further validated using quantitative PCR approach. Functional analysis indicated that hsa-miR-222 inhibits OTSCC cell invasion. Ectopic transfection of hsa-miR-222 reduced the expression of MMP1 and SOD2 in OTSCC cell lines. Direct targeting of hsa-miR-222 to specific sequences located in the 3'-untranslated regions of both MMP1 and SOD2 mRNAs were confirmed using luciferase reporter gene assays. Furthermore, SOD2 knockdown by siRNA led to the downregulation of MMP1 expression. Taken together, these results suggested that hsa-miR-222 regulates the MMP1 expression through both direct cis-regulatory mechanism (targeting MMP1 mRNA) and indirect trans-regulatory mechanism (indirect controlling of MMP1 gene expression by targeting SOD2). Our results indicate that hsa-miR-222 plays an important role in OTSCC invasion, and may serve as a novel therapeutic target for OTSCC patients at risk of metastatic disease.

摘要

微小RNA失调与肿瘤的发生和发展有关。本研究的目的是鉴定并验证促成口腔舌鳞状细胞癌(OTSCC)转移的微小RNA候选物。利用微阵列技术,在具有不同转移潜能的配对OTSCC细胞系中鉴定出一组差异表达的微小RNA。使用定量PCR方法进一步验证了所选的微小RNA候选物(包括hsa-miR-222)。功能分析表明,hsa-miR-222抑制OTSCC细胞侵袭。hsa-miR-222的异位转染降低了OTSCC细胞系中MMP1和SOD2的表达。使用荧光素酶报告基因测定法证实了hsa-miR-222直接靶向位于MMP1和SOD2 mRNA的3'-非翻译区的特定序列。此外,通过siRNA敲低SOD2导致MMP1表达下调。综上所述,这些结果表明,hsa-miR-222通过直接顺式调节机制(靶向MMP1 mRNA)和间接反式调节机制(通过靶向SOD2间接控制MMP1基因表达)调节MMP1表达。我们的结果表明,hsa-miR-222在OTSCC侵袭中起重要作用,并可能作为有转移疾病风险的OTSCC患者的新型治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/2890246/5960fbf3775e/nihms210296f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/2890246/d23919ed9625/nihms210296f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/2890246/583ea49a533a/nihms210296f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/2890246/d39c903ad3d2/nihms210296f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/2890246/8eea8b0248c8/nihms210296f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/2890246/5960fbf3775e/nihms210296f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/2890246/d23919ed9625/nihms210296f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/2890246/583ea49a533a/nihms210296f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/2890246/d39c903ad3d2/nihms210296f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/2890246/8eea8b0248c8/nihms210296f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7af/2890246/5960fbf3775e/nihms210296f5.jpg